期刊文献+

血小板因子4经Toll样受体4上调巨噬细胞基质金属蛋白酶9表达 被引量:6

Platelet Factor 4 Up-regulates the Expression of Matrix Metalloproteinase-9 in Macrophages via Toll-like Receptor 4
下载PDF
导出
摘要 目的观察血小板因子4(PF4)对THP-1单核源性巨噬细胞基质金属蛋白酶9(MMP-9)表达的影响,并初步探讨其机制。方法佛玻酯诱导THP-1细胞分化成巨噬细胞。巨噬细胞经不同浓度PF4(0-200μg/L)处理一定时间后,RT-PCR和Western blot检测MMP-9和Toll样受体4(TLR4)表达。为了研究TLR4在其中的作用,细胞经TLR4阻断剂预处理30 min后,再与PF4孵育特定时间,检测MMP-9表达。结果与对照组比较,50μg/L PF4即可显著上调巨噬细胞MMP-9 mRNA和蛋白水平,至100μg/L时,MMP-9 mRNA和蛋白表达达到最大效应水平,分别较对照组增高约3.8倍(P〈0.001)和1.5(P〈0.01)倍。PF4(100μg/L)也较对照组显著上调TLR4 mRNA和蛋白水平。而加入TLR4阻断剂后可逆转PF4诱导的巨噬细胞MMP-9表达上调,其mRNA和蛋白水平分别较PF4单独孵育组降低约26%和21%(P均〈0.05)。结论 PF4可能通过TLR4上调巨噬细胞MMP-9的表达。 Aim To investigate whether platelet factor 4( PF4) modulates the matrix metalloproteinase-9( MMP-9) expression of macrophages. Methods THP-1 monocytes were differentiated into monocyte-derived macrophages by phorbol 12-myristate 13-acetate( PMA). After incubation with PF4( 0 - 200 μg /L),the MMP-9 expression of macrophages was determined by reverse-transcription polymerase chain reaction( RT-PCR) and Western blot. To determine the role of toll-like receptor 4( TLR4) in the regulation of MMP-9 expression,macrophages were pretreated with TLR4 blocker for 30 min,then incubated with PF4. Results Macrophages that were untreated showed a relatively low MMP-9 and TLR4 mRNA or protein levels; treatment of macrophages with PF4 increased MMP-9 and TLR4 expression. However,the high levels of MMP-9 and TLR4 expression induced by PF4 were significantly attenuated in the presence of TLR4 blocker.Conclusions PF4 may up-regulate MMP-9 expression in macrophages via TLR4.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2014年第8期769-773,共5页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金项目(81100214) 南华大学博士启动基金(2012XQD40)
关键词 血小板因子4 基质金属蛋白酶9 巨噬细胞 TOLL样受体4 Platelet Factor 4 Matrix Metalloproteinase-9 Macrophages Toll-like Receptor 4
  • 相关文献

参考文献1

二级参考文献23

  • 1中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5233
  • 2Wang J, Xu D, Wu X, et al. Polymorphisms of matrix metalloproteinases in myocardial infarction: a meta-analysis [Jl- Heart, 2011, 97(19): 1 542-546.
  • 3Han SW, Kim SH, Lee JY, et al. A new subtype classifi- cation of ischemic stroke based on treatment and etiologic mechanism[J]. Eur Neurol, 2007, 57(2):96-102.
  • 4Newby AC. Dual role of matrix metalloproteinases (ma- trixins) in intimal thickening and atherosclerotic plaque rupture[J]. Physiol Rev, 2005, 85(1) : 1-31.
  • 5Zhou J, Li J, Rosenbaum DM, et al. Thrombopoietin protects the brain and improves sensorimotor functions: reduction of stroke-induced MMP-9 upregulation and blood-brain barrier injury [ J ]. J Cereb Blood Flow Metab, 2011, 31(3) : 924-933.
  • 6Barr TL, Latour LL, Lee KY, et al. Blood-brain barrier disruption in humans is independently associated with in- creased matrix metalloproteinase-9 [ J ]. Stroke, 2010, 41 (3) : e123-e128.
  • 7Rosell A, Ortega-Aznar A, Alvarez-Sabfn J, et al. In- creased brain expression of matrix metalloproteinase-9 af- ter ischemic and hemorrhagic human stroke [ J ]. Stroke, 2006, 37(6): 1 399-406.
  • 8Zhao BQ, Wang S, Kim HY, et al. Role of matrix metal- loproteinases in delayed cortical responses after stroke [J]. Nat ned, 2006, 12(4) : 441-445.
  • 9Ulrich NH, Dehmel T, Wittsaek YIJ, et al. Peripheral blood levels of matrix metalloproteinase-9 predict lesion volume in acute stroke[J]. Neurol Sci, 2013, 34(3) : 379-382.
  • 10Ramos-Fernandez M, Bellolio MF, Stead LG. Matrix met- alloproteinase-9 as a marker for acute ischemic stroke: a systematic review [ J ]. J Stroke Cerebrovasc Dis, 2011, 20 ( 1 ) : 47-54.

共引文献9

同被引文献108

  • 1王志飞,谢颖桢,谢雁鸣,赵德喜,王敏忠,于海青,曹晓岚,李博,编制组.芪龙胶囊临床应用专家共识[J].中国中药杂志,2019,44(24):5287-5290. 被引量:11
  • 2卞敬琦,牛雯颖,冯月男,张玉昆,肖洪彬.补阳还五汤对气虚血瘀模型血小板活化影响[J].辽宁中医药大学学报,2020,0(2):43-46. 被引量:24
  • 3陈可冀,李连达,翁维良.血瘀证与活血化瘀研究[J].中西医结合心脑血管病杂志,2005,3(1):1-2. 被引量:243
  • 4成秀梅,杜惠兰,李丹.寒凝血瘀证动物模型的创建[J].中国中医基础医学杂志,2005,11(8):604-605. 被引量:95
  • 5Libby P.Inflammation in atherosclerosis[J].Nature,2002,420(6917):868-874.
  • 6Gleissner CA.Platelet-derived chemokines in atherogenesis:what's new[J]?Curr Vasc Pharmacol,2012,10(5):563-569.
  • 7Sachais BS,Turrentine T,Dawicki Mc Kenna JM,et al.Elimination of platelet factor 4(PF4)from platelets reduces atherosclerosis in C57Bl/6 and apo E-/-mice[J].Thromb Haemost,2007,98(5):1108-1113.
  • 8Chen Q,Jin M,Yang F,et al.Matrix metalloproteinases:inflammatory regulators of cell behaviors in vascular formation and remodeling[J].Mediators Inflamm,2013,2013:928315.
  • 9Pamukcu B,Lip GY,Shantsila E.The nuclear factor--kappa B pathway in atherosclerosis:a potential therapeutic target for atherothrombotic vascular disease[J].Thromb Res,2011,128(2):117-123.
  • 10Hu ZP,Fang XL,Fang N,et al.Melatonin ameliorates vascular endothelial dysfunction,inflammation,andatherosclerosis by suppressing the TLR4/NF-κB system in high-fat-fed rabbits[J].J Pineal Res,2013,55(4):388-398.

引证文献6

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部